Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort

被引:18
作者
Shen, Cong-rong [1 ,2 ,3 ,4 ,5 ]
Jia, Xiao-yu [1 ,2 ,3 ,4 ,5 ]
Cui, Zhao [1 ,2 ,3 ,4 ,5 ]
Yu, Xiao-juan [1 ,2 ,3 ,4 ,5 ]
Zhao, Ming-hui [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Peking Univ First Hosp, Renal Div, Beijing, Peoples R China
[2] Peking Univ, Inst Nephrol, Beijing, Peoples R China
[3] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China
[4] Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Res Units Diag & Treatment Immune Mediated Kidney, Beijing, Peoples R China
[6] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
基金
中国国家自然科学基金;
关键词
anti-GBM disease; crescentic glomerulonephritis; rapidly progressive glomerulonephritis; renal outcome; renal pathology; GOODPASTURE-SYNDROME; ANTIBODY DISEASE; PATIENT; GLOMERULONEPHRITIS;
D O I
10.3389/fimmu.2020.02035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:Atypical cases of anti-glomerular basement membrane (GBM) disease had absent circulating antibodies but linear IgG deposits along GBM in the kidneys. Herein, we reported the clinical-pathological features and outcome of these rare cases. Methods:Linear IgG deposit along GBM were examined by immunofluorescence on renal specimens, with exclusion of diabetic kidney disease. Circulating anti-GBM antibodies were tested by commercial ELISA assay. Clinical, pathological and follow-up data were retrospectively analyzed. Results:From 2013 to 2018, a total of 60 patients were diagnosed as atypical anti-GBM disease. They had a male predominance, with an average age of 51.7 +/- 15.6 years. Three (5.0%) patients had alveolar hemorrhage. Forty five percent of them presented with acute kidney disease. All patients had linear IgG deposit along GBM, some in addition on tubular basement membrane and/or Bowmans' capsules. C3 deposition was found in 65.0% of the patients. 41.7% (25/60) of the patients showed crescent formation and the percentage of crescent was (34.7 +/- 23.5)% in those patients. They had higher prevalence of hematuria and C3 deposit, higher levels of serum creatinine, worse renal and patient survival than those without crescent (P< 0.05). During the follow-up of 35.7 +/- 21.4 months, 14 (23.3%) patients progressed to ESRD. The serum creatinine on diagnosis [per 200 mu mol/L increase, HR (95% CI): 2.663 (1.372, 5.172),P= 0.004], serum C3 [per 0.1 g/L increase, HR (95% CI): 0.689(0.483, 0.984),P= 0.040] and the intensity of kidney C3 staining [per 1+ increase, HR (95% CI): 2.770 (1.115, 6.877),P= 0.028] were independent predictive factors for kidney outcome. Nine (15.0%) patients died of all causes. Conclusions:Atypical anti-GBM disease manifested milder kidney injury and scarce pulmonary hemorrhage compared to the classical cases. Though heterogeneous, a substantial number of the patients had complement activation and crescent formation. Patients having crescents presented with more severe clinical course and worse outcomes. The poor kidney and patient prognosis emphasize prompt interventions from physicians. The immunosuppressive intervention was not associated with kidney or patient outcome. Further studies are needed to address the optimal therapeutic regimen.
引用
收藏
页数:9
相关论文
共 34 条
[1]  
ANDREWS PA, 1995, CLIN NEPHROL, V44, P262
[2]   Binding Truths: Atypical Anti - Glomerular Basement Membrane Disease Mediated by IgA Anti - Glomerular Basement Membrane Antibodies Targeting the α1 Chain of Type IV Collagen [J].
Antonelou, Marilina ;
Henderson, Scott R. ;
Bhangal, Gurjeet ;
Heptinstall, Lauren ;
Oliveira, Ben ;
Hamour, Sally ;
Harber, Mark ;
Salama, Alan D. .
KIDNEY INTERNATIONAL REPORTS, 2019, 4 (01) :163-167
[3]  
Benz K, 2007, CLIN NEPHROL, V67, P240
[4]   Goodpasture syndrome during the course of a Schonlein-Henoch purpura: [J].
Carreras, L ;
Poveda, R ;
Bas, J ;
Mestre, M ;
Rama, I ;
Carrera, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) :E21
[5]   The complement system in systemic autoimmune disease [J].
Chen, Min ;
Daha, Mohamed R. ;
Kallenberg, Cees G. M. .
JOURNAL OF AUTOIMMUNITY, 2010, 34 (03) :J276-J286
[6]   Antiglomerular basement membrane disease with normal renal function [J].
Cui, Z. ;
Zhao, M-h ;
Singh, A. K. ;
Wang, H-Y .
KIDNEY INTERNATIONAL, 2007, 72 (11) :1403-1408
[7]   Concurrent antiglomerular basement membrane disease and immune complex glomerulonephritis [J].
Cui, Z ;
Zhao, MH ;
Wang, SX ;
Liu, G ;
Zou, WZ ;
Wang, HY .
RENAL FAILURE, 2006, 28 (01) :7-14
[8]   Characteristics and prognosis of chinese patients with anti-glomerular basement membrane disease [J].
Cui, Z ;
Zhao, MH ;
Xin, G ;
Wang, HY .
NEPHRON CLINICAL PRACTICE, 2005, 99 (02) :C49-C55
[9]   Advances in human antiglomerular basement membrane disease [J].
Cui, Zhao ;
Zhao, Ming-Hui .
NATURE REVIEWS NEPHROLOGY, 2011, 7 (12) :697-705
[10]   Anti-Glomerular Basement Membrane Disease Outcomes of Different Therapeutic Regimens in a Large Single-Center Chinese Cohort Study [J].
Cui, Zhao ;
Zhao, Juan ;
Jia, Xiao-yu ;
Zhu, Sai-nan ;
Jin, Qi-zhuang ;
Cheng, Xu-yang ;
Zhao, Ming-hui .
MEDICINE, 2011, 90 (05) :303-311